• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何对稳定期慢性阻塞性肺疾病男性患者进行气流受限分级?

How to Stage Airflow Limitation in Stable Chronic Obstructive Pulmonary Disease Male Patients?

机构信息

Laboratory of Physiology and Functional Explorations, Farhat HACHED Hospital, Sousse, Tunisia.

Heart Failure (LR12SP09) Research Laboratory, Farhat HACHED Hospital, Sousse, Tunisia.

出版信息

Am J Mens Health. 2020 May-Jun;14(3):1557988320922630. doi: 10.1177/1557988320922630.

DOI:10.1177/1557988320922630
PMID:32475199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7263160/
Abstract

No study has evaluated the utility of different classifications of chronic obstructive pulmonary disease (COPD) airflow limitation (AFL) in terms of the refined "ABCD" classification of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) or in terms of the impacts on quality of life. This study aimed to compare some relevant health outcomes (i.e., GOLD classification and quality-of-life scores) between COPD patients having "light" and "severe" AFL according to five COPD AFL classifications. It was a cross-sectional prospective study including 55 stable COPD male patients. The COPD assessment test (CAT), the VQ11 quality-of-life questionnaire, a spirometry, and a bronchodilator test were performed. The patients were divided into GOLD "A/B" and "C/D." The following five classifications of AFL severity, based on different post-bronchodilator forced expiratory volume in 1 s (FEV) expressions, were applied: FEV: "light" (≥50), "severe" (<50); FEV: "light" (≥-3), "severe" (<-3); FEV/height: "light" (≥0.40), "severe" (<0.40); FEV/height: "light" (≥0.29), "severe" (<0.29); and FEV: "light" (≥2.50), "severe" (<2.50). The percentages of the patients with "severe" AFL were significantly influenced by the applied classification of the AFL severity (89.1 [FEV], 63.6 [FEV], 41.8 [FEV/height], 40.0 [FEV], and 25.4 [FEV/height]; Cochrane test = 91.49, df = 4). The CAT and VQ11 scores were significantly different between the patients having "light" and "severe" AFL. In GOLD "C/D" patients, only the FEV was able to distinguish between the two AFL severities. To conclude, the five classifications of COPD AFL were not similar when compared with regard to some relevant health outcomes.

摘要

尚无研究评估慢性阻塞性肺疾病(COPD)气流受限(AFL)的不同分类在全球慢性阻塞性肺疾病倡议(GOLD)的“ABCD”精细分类或对生活质量的影响方面的效用。本研究旨在比较根据五种 COPD AFL 分类,根据 COPD AFL 严重程度分类(即 GOLD 分类和生活质量评分),COPD 患者中“轻度”和“重度”AFL 的一些相关健康结果。这是一项包括 55 例稳定 COPD 男性患者的横断面前瞻性研究。进行了 COPD 评估测试(CAT)、VQ11 生活质量问卷、肺量测定和支气管扩张剂测试。患者被分为 GOLD“A/B”和“C/D”。应用以下五种不同的 AFL 严重程度分类,基于不同的支气管扩张剂后 1 秒用力呼气量(FEV)表达:FEV:“轻度”(≥50),“重度”(<50);FEV:“轻度”(≥-3),“重度”(< -3);FEV/身高:“轻度”(≥0.40),“重度”(<0.40);FEV/身高:“轻度”(≥0.29),“重度”(<0.29);和 FEV:“轻度”(≥2.50),“重度”(<2.50)。应用的 AFL 严重程度分类显著影响“重度”AFL 患者的比例(89.1[FEV]、63.6[FEV]、41.8[FEV/身高]、40.0[FEV]和 25.4[FEV/身高];Cochrane 检验=91.49,df=4)。CAT 和 VQ11 评分在“轻度”和“重度”AFL 患者之间存在显著差异。在 GOLD“C/D”患者中,只有 FEV 能够区分两种 AFL 严重程度。总之,当涉及一些相关健康结果时,COPD AFL 的五种分类并不相似。

相似文献

1
How to Stage Airflow Limitation in Stable Chronic Obstructive Pulmonary Disease Male Patients?如何对稳定期慢性阻塞性肺疾病男性患者进行气流受限分级?
Am J Mens Health. 2020 May-Jun;14(3):1557988320922630. doi: 10.1177/1557988320922630.
2
Influences of Two FEV Reference Equations (GLI-2012 and GIRH-2017) on Airflow Limitation Classification Among COPD Patients.两种 FEV 参考方程(GLI-2012 和 GIRH-2017)对 COPD 患者气流受限分类的影响。
Int J Chron Obstruct Pulmon Dis. 2022 Sep 2;17:2053-2065. doi: 10.2147/COPD.S373834. eCollection 2022.
3
Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Australians perspective study.使用 GLI-2012、GOLD 和澳大利亚 COPD-X 建议评估 COPD 土著人群中肺功能气流受限严重程度的影响:一项澳大利亚土著人视角的研究。
BMJ Open Respir Res. 2021 Dec;8(1). doi: 10.1136/bmjresp-2021-001135.
4
Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中用于分类通气功能障碍的用力呼气量绝对值与预测值之间的差异。
Respir Med. 2016 Feb;111:30-8. doi: 10.1016/j.rmed.2015.11.004. Epub 2015 Nov 11.
5
Diagnosis of COPD and clinical course in patients with unrecognized airflow limitation.未识别气流受限患者 COPD 的诊断和临床病程。
Int J Chron Obstruct Pulmon Dis. 2013;8:199-208. doi: 10.2147/COPD.S39555. Epub 2013 Apr 18.
6
Classification of Airflow Limitation Based on z-Score Underestimates Mortality in Patients with Chronic Obstructive Pulmonary Disease.基于 z 评分的气流受限分类低估了慢性阻塞性肺疾病患者的死亡率。
Am J Respir Crit Care Med. 2017 Aug 1;196(3):298-305. doi: 10.1164/rccm.201611-2265OC.
7
[Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].[采用层次聚类分析和两步聚类分析对症状性慢性气道疾病临床表型的研究]
Zhonghua Nei Ke Za Zhi. 2016 Sep 1;55(9):679-83. doi: 10.3760/cma.j.issn.0578-1426.2016.09.005.
8
[Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test in chronic obstructive pulmonary disease with severe airflow limitation].慢性阻塞性肺疾病评估测试在严重气流受限的慢性阻塞性肺疾病中的应用价值
Med Clin (Barc). 2014 Oct 21;143(8):349-51. doi: 10.1016/j.medcli.2013.08.006. Epub 2013 Nov 7.
9
Asthma masquerading as chronic obstructive pulmonary disease: a study of smokers fulfilling the GOLD definition of chronic obstructive pulmonary disease.哮喘伪装成慢性阻塞性肺疾病:一项符合 GOLD 慢性阻塞性肺疾病定义的吸烟者研究。
Respiration. 2011;82(1):19-27. doi: 10.1159/000323075. Epub 2011 Jan 29.
10
Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.在泰国慢性阻塞性肺疾病严重程度分级中,呼气峰值流速作为一秒用力呼气量的替代指标。
Int J Chron Obstruct Pulmon Dis. 2015 Jun 25;10:1213-8. doi: 10.2147/COPD.S85166. eCollection 2015.

引用本文的文献

1
Routine pulmonary lung function tests: Interpretative strategies and challenges.常规肺功能测试:解读策略与挑战。
Chron Respir Dis. 2024 Jan-Dec;21:14799731241307252. doi: 10.1177/14799731241307252.
2
[Not Available].[无可用内容]。
Tunis Med. 2023 Mar 5;101(3):323-333.
3
Influences of Two FEV Reference Equations (GLI-2012 and GIRH-2017) on Airflow Limitation Classification Among COPD Patients.两种 FEV 参考方程(GLI-2012 和 GIRH-2017)对 COPD 患者气流受限分类的影响。
Int J Chron Obstruct Pulmon Dis. 2022 Sep 2;17:2053-2065. doi: 10.2147/COPD.S373834. eCollection 2022.
4
Comments on "Anthropometric, Psychosocial, Physiological, and Postural Observances During Ramadan in Men With Chronic Obstructive Pulmonary Disease".关于“慢性阻塞性肺疾病男性在斋月期间的人体测量、心理社会、生理和姿势观察”的评论
Am J Mens Health. 2022 May-Jun;16(3):15579883221099427. doi: 10.1177/15579883221099427.
5
Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Australians perspective study.使用 GLI-2012、GOLD 和澳大利亚 COPD-X 建议评估 COPD 土著人群中肺功能气流受限严重程度的影响:一项澳大利亚土著人视角的研究。
BMJ Open Respir Res. 2021 Dec;8(1). doi: 10.1136/bmjresp-2021-001135.

本文引用的文献

1
FEV as a Standalone Spirometric Predictor and the Attributable Fraction for Death in Older Persons.FEV 作为一项独立的肺量计预测指标和老年人死亡的归因分数。
Respir Care. 2020 Feb;65(2):217-226. doi: 10.4187/respcare.07012. Epub 2019 Oct 29.
2
Status of and strategies for improving adherence to COPD treatment.COPD 治疗依从性的现状和改善策略。
Int J Chron Obstruct Pulmon Dis. 2019 Jul 10;14:1503-1515. doi: 10.2147/COPD.S170848. eCollection 2019.
3
It is time for the world to take COPD seriously: a statement from the GOLD board of directors.全球慢性阻塞性肺疾病倡议(GOLD)董事会声明:是时候让世界认真对待慢性阻塞性肺疾病了。
Eur Respir J. 2019 Jul 4;54(1). doi: 10.1183/13993003.00914-2019. Print 2019 Jul.
4
The Effects of Ramadan-Fasting (RF) on Inflammatory and Hematological Indices of Stable Chronic Obstructive Pulmonary Disease (COPD) Male Patients: A Pilot Study.拉马丹禁食(RF)对稳定期慢性阻塞性肺疾病(COPD)男性患者炎症和血液学指标的影响:一项初步研究。
Am J Mens Health. 2018 Nov;12(6):2089-2103. doi: 10.1177/1557988318794304. Epub 2018 Aug 17.
5
Comparison of different staging methods for COPD in predicting outcomes.比较不同分期方法在预测 COPD 结局中的作用。
Eur Respir J. 2018 Mar 15;51(3). doi: 10.1183/13993003.00577-2017. Print 2018 Mar.
6
The revised GOLD 2017 COPD categorization in relation to comorbidities.修订版 GOLD 2017 COPD 分类与合并症的关系。
Respir Med. 2018 Jan;134:79-85. doi: 10.1016/j.rmed.2017.12.003. Epub 2017 Dec 5.
7
COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update.COPD-X 澳大利亚和新西兰慢性阻塞性肺疾病诊断和管理指南:2017 年更新版。
Med J Aust. 2017 Nov 20;207(10):436-442. doi: 10.5694/mja17.00686.
8
[Evaluation of quality of life (QOL) of Tunisians patients with COPD].[突尼斯慢性阻塞性肺疾病患者的生活质量评估]
Rev Pneumol Clin. 2017 Oct;73(5):231-239. doi: 10.1016/j.pneumo.2017.08.004. Epub 2017 Oct 18.
9
Severity of Airflow Obstruction in Chronic Obstructive Pulmonary Disease (COPD): Proposal for a New Classification.慢性阻塞性肺疾病(COPD)气流受限严重程度的新分类建议。
COPD. 2017 Oct;14(5):469-475. doi: 10.1080/15412555.2017.1339681. Epub 2017 Aug 11.
10
Predictive Value of Different Expressions of Forced Expiratory Volume in 1 Second (FEV1) for Adverse Outcomes in a Cohort of Adults Aged 80 and Older.1秒用力呼气量(FEV1)不同表达对80岁及以上成年人群不良结局的预测价值
J Am Med Dir Assoc. 2017 Feb 1;18(2):123-130. doi: 10.1016/j.jamda.2016.08.012. Epub 2016 Oct 14.